Literature DB >> 14689494

Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering.

Julian R Jones1, Larry L Hench.   

Abstract

Resorbable 3D macroporous bioactive scaffolds have been produced for tissue-engineering applications by foaming sol-gel-derived bioactive glasses of the 58S (60 mol% SiO2, 36 mol% CaO, 4 mol% P2O5) composition with the aid of a surfactant. Bioactive glasses are known to have the ability to regenerate bone, and to release ionic biological stimuli that promote bone-cell proliferation by gene activation. The foams exhibit a hierarchical structure, with interconnected macropores (10-500 microm), which provide the potential for tissue ingrowth and mesopores (2-50 nm), which enhance bioactivity and release of ionic products. Many factors in the sol-gel and foaming processes can be used to control these pore sizes and distributions. This work concentrates on the effect of the processing temperature, gelling agent concentration, and the amount of water used for the foam generation on the structure, pore morphology, and the properties of the foam scaffold. The simplest and most reproducible method for controlling the modal pore diameter was by the amount of water added during the foaming process. The in vitro dissolution and bioactivity of the bioactive foams were compared to that of unfoamed monoliths and powders (< 20 microm in diameter) of the same composition. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14689494     DOI: 10.1002/jbm.b.10071

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  20 in total

1.  Controlling ion release from bioactive glass foam scaffolds with antibacterial properties.

Authors:  Julian R Jones; Lisa M Ehrenfried; Priya Saravanapavan; Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

Review 2.  Gene activation by bioactive glasses.

Authors:  G Jell; M M Stevens
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

3.  Preparation of porous 45S5 Bioglass-derived glass-ceramic scaffolds by using rice husk as a porogen additive.

Authors:  Shih-Ching Wu; Hsueh-Chuan Hsu; Sheng-Hung Hsiao; Wen-Fu Ho
Journal:  J Mater Sci Mater Med       Date:  2009-01-22       Impact factor: 3.896

Review 4.  Promising trends of bioceramics in the biomaterials field.

Authors:  D Arcos; I Izquierdo-Barba; M Vallet-Regí
Journal:  J Mater Sci Mater Med       Date:  2008-11-06       Impact factor: 3.896

5.  Twenty-first century challenges for biomaterials.

Authors:  Larry L Hench; Ian Thompson
Journal:  J R Soc Interface       Date:  2010-05-19       Impact factor: 4.118

Review 6.  Recent advances and future perspectives of sol-gel derived porous bioactive glasses: a review.

Authors:  Kalim Deshmukh; Tomáš Kovářík; Tomáš Křenek; Denitsa Docheva; Theresia Stich; Josef Pola
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 4.036

7.  Exposure of the murine RAW 264.7 macrophage cell line to dicalcium silicate coating: assessment of cytotoxicity and pro-inflammatory effects.

Authors:  Liangjiao Chen; Yanli Zhang; Jia Liu; Limin Wei; Bin Song; Longquan Shao
Journal:  J Mater Sci Mater Med       Date:  2016-01-22       Impact factor: 3.896

8.  A novel bioactive porous bredigite (Ca7MgSi4O16) scaffold with biomimetic apatite layer for bone tissue engineering.

Authors:  Chengtie Wu; Jiang Chang; Wanyin Zhai; Siyu Ni
Journal:  J Mater Sci Mater Med       Date:  2007-01-09       Impact factor: 4.727

Review 9.  Bioceramics and Scaffolds: A Winning Combination for Tissue Engineering.

Authors:  Francesco Baino; Giorgia Novajra; Chiara Vitale-Brovarone
Journal:  Front Bioeng Biotechnol       Date:  2015-12-17

10.  Functionalized mesoporous bioactive glass scaffolds for enhanced bone tissue regeneration.

Authors:  Xingdi Zhang; Deliang Zeng; Nan Li; Jin Wen; Xinquan Jiang; Changsheng Liu; Yongsheng Li
Journal:  Sci Rep       Date:  2016-01-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.